Patient Hubs Continue Growth
PharmExec
JANUARY 11, 2023
How technology will play a big role in advancing pharma approaches in patient support.
PharmExec
JANUARY 11, 2023
How technology will play a big role in advancing pharma approaches in patient support.
Pharmaceutical Technology
JUNE 7, 2023
Shanghai Fosun Pharmaceutical (Group) is to collaborate with the International Finance Corporation (IFC) to construct a new pharmaceutical production facility and distribution hub near Abidjan, Côte d’Ivoire. The IFC will provide two loans totalling $53.49m (€50m) to Fosun Pharma’s subsidiaries.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
DECEMBER 21, 2022
The agreement focuses on collaboration in four key areas including localising innovative industries, R&D , innovation and sustainability at a global scale to enhance the United Arab Emirates (UAE’s) position as a global hub for future industries.
World of DTC Marketing
JANUARY 12, 2022
Scandals, fake followers, bot technologies, and the pandemic crisis converged have put a halt to influencer marketing growth and tarnished the public view of influencers as a whole. billion in 2020, according to Influencer Marketing Hub , which estimated the market would grow to $13.8 billion in 2021.
European Pharmaceutical Review
JUNE 27, 2022
Marc Dunoyer, Chief Executive Officer (CEO) of Alexion, stated “We are delighted to be further investing in our facilities in Ireland, an increasingly critical global hub for AstraZeneca operations, to support the continued growth of Alexion’s portfolio of medicines and meet our needs for expansion.
PM360
SEPTEMBER 21, 2023
As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. 1 We have been improving patient affordability for over a decade, across generic and brand medications, including specialty treatments—sometimes by more than 50%.
pharmaphorum
DECEMBER 18, 2022
We live in unprecedented times, where innovation in biosciences continues to accelerate. Science has taken a vertical growth trajectory, yet such innovations are, at best, slow to reach the patients in need. Why current patient access solutions have come up short. Why current patient access solutions have come up short.
Let's personalize your content